70 results
Page 2 of 4
8-K
EX-99.1
d1ule5ri
27 Sep 22
Other Events
9:28am
425
9xu6nyzmp
7 Sep 22
Business combination disclosure
5:00pm
425
p36e 8dyfj
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
yt3 3evc0kldv7
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
2pjh3susf9g9bfok5 1r
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K/A
EX-99.1
b9jvb8x
2 May 22
Financial Statements and Exhibits
1:19pm
8-K
EX-99.1
2q8b3h nssfx599
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
EX-99.1
uaomv9
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
EX-99.1
s40g6a 2b
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.2
1qwo 7t1odv
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-2.1
rds0bw2
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
EX-99.1
axoy5k88ivia c1up8ae
12 Feb 21
Regulation FD Disclosure
3:05pm
8-K
EX-1.1
bwjym16 8f8gvfzi86
14 Aug 20
Equillium Announces Proposed Public Offering of Common Stock
4:50pm